시장보고서
상품코드
1838590

비알코올성 지방간염 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종사용자, 스테이지, 모드, 솔루션

Non alcoholic Steatohepatitis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Stage, Mode, Solutions

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 354 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

비알코올성 지방간염 시장은 2024년 119억 달러에서 2034년 1,029억 달러로 약 24.1%의 CAGR로 성장할 것으로 예상됩니다. 비알코올성 지방간염(NASH) 시장은 알코올 관련을 제외한 지방 축적으로 인한 간 염증 및 손상을 표적으로 하는 치료 솔루션 개발 및 시장 개발을 포괄합니다. 비만율 증가, 좌식 생활습관, 간 건강에 대한 인식의 증가가 이 시장을 주도하고 있습니다. 이 시장에는 의약품, 진단, 생활습관 개입이 포함되며, 혁신적인 치료법과 조기 발견에 중점을 두고 있습니다. NASH는 간경변증과 간암으로 발전할 수 있기 때문에 효과적인 치료법에 대한 수요가 증가하고 있으며, 이에 따라 빠르게 성장하는 이 분야에 대한 연구와 투자가 촉진되고 있습니다.

비알코올성 지방간염(NASH) 시장은 인지도 향상과 유병률 증가에 힘입어 견조한 성장이 예상됩니다. 치료 분야에서는 의약품 개발의 진전이 기대되는 치료제 분야가 주도할 것으로 예상됩니다. 특히, 섬유증 치료제는 중요한 질환 진행 단계에 대응하기 때문에 이 분야에서 최고의 실적을 올릴 것으로 예상됩니다. 그 뒤를 잇는 진단 분야는 조기에 정확한 질병 발견의 필요성을 반영하여 더욱 탄력을 받고 있습니다. 영상 진단 기술 및 바이오마커 식별혁신은 진단 능력을 향상시키고 비침습적 옵션을 더욱 매력적으로 만들고 있습니다. 식이요법과 운동 요법에 초점을 맞춘 생활습관 관리 하위 부문도 NASH를 관리하기 위한 총체적 접근법이 지지받으면서 성장세를 보이고 있습니다. 제약 기업 간의 전략적 제휴와 파트너십은 연구개발 노력을 가속화하고 시장 역동성을 더욱 촉진하고 있습니다. 효과적인 NASH 솔루션에 대한 수요가 증가함에 따라 이해관계자들은 새로운 치료 및 진단 혁신에 대한 투자를 늘리고 있습니다.

시장 세분화
유형 바이오마커, 치료제, 진단
제품 의약품, 생물학적 제제, 식이보충제, 의료기기
서비스 임상시험, 컨설팅 서비스, 환자 지원 서비스, 약사 서비스
기술 유전체학, 단백질체학, 바이오인포매틱스, 이미징 기술
용도 간생검, 영상 검사, 혈액 검사
최종사용자 병원, 클리닉, 조사기관, 제약회사
스테이지 전임상, 단계 I, 단계 II, 단계 III
모드 침습적, 비침습적
솔루션 치료 솔루션, 진단 솔루션

시장 스냅샷

비알코올성 지방간염(NASH) 시장은 주요 제약사들이 큰 비중을 차지하는 역동적인 시장 환경이 특징입니다. 가격 전략은 혁신적인 치료 솔루션에 대한 높은 수요의 영향을 받아 여전히 경쟁력이 있습니다. 최근 제품 출시로 인해 획기적인 치료법이 도입되어 의료진이 이용할 수 있는 치료 수단이 다양해졌습니다. 이에 따라 각 기업들은 차별화된 제품 제공과 전략적 제휴를 통해 시장 패권을 다투고 있으며, 가격 경쟁 환경은 더욱 치열해지고 있습니다. 시장은 R&D 투자가 급증하고 있으며, 신약 후보물질의 도입을 촉진하고 있습니다. 경쟁 벤치마킹에서 NASH 시장은 치열한 경쟁 상태이며, 주요 기업들은 전략적 인수합병에 중점을 두고 시장 지위를 강화하는 데 주력하고 있습니다. 규제의 영향은 매우 크며, 엄격한 가이드라인이 NASH 치료제의 승인과 상용화를 형성하고 있습니다. 북미와 유럽의 규제 상황은 특히 영향력이 크며, 임상적 효과와 안전성에 대해 높은 기준을 설정하고 있습니다. 이러한 규제의 강화와 환자들의 인식이 높아지면서 시장의 진화를 촉진하고 있습니다. 혁신적인 치료 접근법을 도입하는 신생 생명공학 기업들에 의해 경쟁은 더욱 치열해지고 있으며, 이로 인해 시장 역학이 재편되고 있습니다.

주요 동향과 촉진요인:

비알코올성 지방간염(NASH) 시장은 비만과 제2형 당뇨병의 유병률 증가로 인해 괄목할만한 성장세를 보이고 있습니다. 이들 질환은 NASH의 주요 위험 요인으로 효과적인 치료법에 대한 수요를 견인하고 있습니다. 중요한 트렌드는 질병 진행에 관여하는 특정 경로를 표적으로 하는 새로운 치료제의 개발입니다. 제약회사들은 간 손상을 막거나 회복시킬 수 있는 혁신적인 약물을 발견하기 위해 연구에 투자하고 있습니다. 간 건강 및 조기 진단에 대한 인식이 높아지는 것도 시장 성장을 촉진하고 있습니다. 의료 서비스 제공자는 선별검사와 조기 개입의 중요성을 강조하고, 환자 참여도를 높이고 있습니다. 또한, 진단 기술의 발전으로 보다 정확하고 비침습적인 NASH 검출 방법이 가능해졌습니다. 유망한 치료법에 대한 규제 당국의 지원과 신속한 승인 절차가 시장 확대를 더욱 가속화하고 있습니다. 전 세계적으로 맞춤형 의료에 대한 관심이 높아지면서 환자 치료 결과를 개선할 수 있는 맞춤형 치료 접근법이 등장하고 있습니다. NASH의 병태생리에 대한 이해가 깊어짐에 따라 시장은 혁신적 진전을 이루며 유리한 비즈니스 기회를 얻을 준비가 되어 있습니다.

억제요인과 과제:

비알코올성 지방간염(NASH) 시장은 몇 가지 중요한 억제요인과 도전에 직면해 있습니다. 가장 큰 문제는 NASH의 정확한 진단이 복잡하다는 점입니다. NASH를 진단하기 위해서는 침습적인 간 생검이 필요한 경우가 많은데, 이는 환자에게는 비용과 위험 부담이 큽니다. 이러한 진단의 복잡성으로 인해 조기 발견과 조기 개입이 제한되어 시장 성장을 저해하고 있습니다. 또 다른 제약은 NASH에 특화된 치료법이 승인되지 않아 적응증 외 치료에 의존할 수밖에 없다는 점입니다. 이러한 표적 치료제의 부재는 치료 옵션과 시장 확대를 제한합니다. 또한, 지속적인 연구개발에 소요되는 높은 비용이 경제적 부담으로 작용하여 중소기업의 시장 진입을 가로막고 있습니다. 또한, 환자마다 질환의 진행에 차이가 있기 때문에 임상시험의 설계와 결과가 복잡해지는 문제도 있습니다. 마지막으로, 의료진과 환자 모두 NASH에 대한 인식과 이해가 일반적으로 부족하여 조기 진단과 조기 치료를 방해하고 결국 시장 성장을 저해하는 요인으로 작용하고 있습니다.

주요 플레이어

Intercept Pharmaceuticals, Genfit, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Viking Therapeutics, Akero Therapeutics, 89bio, Terns Pharmaceuticals, Inventiva, Cirius Therapeutics, Enyo Pharma, Conatus Pharmaceuticals, Gilead Sciences, Allergan, Novartis

목차

제1장 비알코올성 지방간염 시장 개요

  • 조사 목적
  • 비알코올성 지방간염 시장 정의와 조사 범위
  • 보고서 제한사항
  • 조사 대상 연도와 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 주요 인사이트

제4장 비알코올성 지방간염 시장 전망

  • 비알코올성 지방간염 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 비알코올성 지방간염 시장 전략

  • 상부 시장 분석
  • 수급 분석
  • 소비자 구매 관심
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 비알코올성 지방간염 시장 규모

  • 비알코올성 지방간염 시장 규모 : 금액별
  • 비알코올성 지방간염 시장 규모 : 수량별

제7장 비알코올성 지방간염 시장 규모 : 유형별

  • 시장 개요
  • 바이오마커
  • 치료제
  • 진단
  • 기타

제8장 비알코올성 지방간염 시장 : 제품별

  • 시장 개요
  • 의약품
  • 생물학적 제제
  • 식이보충제
  • 의료기기
  • 기타

제9장 비알코올성 지방간염 시장 : 서비스별

  • 시장 개요
  • 임상시험
  • 컨설팅 서비스
  • 환자 지원 서비스
  • 약사 서비스
  • 기타

제10장 비알코올성 지방간염 시장 : 기술별

  • 시장 개요
  • 유전체학
  • 단백질체학
  • 바이오인포매틱스
  • 이미징 기술
  • 기타

제11장 비알코올성 지방간염 시장 : 용도별

  • 시장 개요
  • 간생검
  • 영상 검사
  • 혈액 검사
  • 기타

제12장 비알코올성 지방간염 시장 : 최종사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 연구기관
  • 제약회사
  • 기타

제13장 비알코올성 지방간염 시장 : 스테이지별

  • 시장 개요
  • 전임상시험
  • 단계 I
  • 단계 II
  • 단계 III
  • 기타

제14장 비알코올성 지방간염 시장 : 모드별

  • 시장 개요
  • 침습성
  • 비침습적
  • 기타

제15장 비알코올성 지방간염 시장 : 솔루션별

  • 시장 개요
  • 치료 솔루션
  • 진단 솔루션
  • 기타

제16장 비알코올성 지방간염 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제18장 기업 개요

  • Intercept Pharmaceuticals
  • Genfit
  • Madrigal Pharmaceuticals
  • Galmed Pharmaceuticals
  • Viking Therapeutics
  • Akero Therapeutics
  • 89bio
  • Terns Pharmaceuticals
  • Inventiva
  • Cirius Therapeutics
  • Enyo Pharma
  • Conatus Pharmaceuticals
  • Gilead Sciences
  • Allergan
  • Novartis
KSM 25.11.04

Non alcoholic Steatohepatitis Market is anticipated to expand from $11.9 billion in 2024 to $102.9 billion by 2034, growing at a CAGR of approximately 24.1%. The Non-Alcoholic Steatohepatitis (NASH) Market encompasses the development and commercialization of therapeutic solutions targeting liver inflammation and damage due to fat accumulation, excluding alcohol-related causes. This market is driven by rising obesity rates, sedentary lifestyles, and increasing awareness of liver health. It includes pharmaceuticals, diagnostics, and lifestyle interventions, with a focus on innovative therapies and early detection methods. As NASH can progress to cirrhosis or liver cancer, the demand for effective treatments is intensifying, fostering research and investment in this burgeoning field.

The Non-Alcoholic Steatohepatitis (NASH) Market is poised for robust expansion, driven by rising awareness and increasing prevalence. Within the treatment landscape, the therapeutics segment is expected to lead, with promising advancements in drug development. Specifically, the fibrosis treatment sub-segment is anticipated to be the top-performing area, as it addresses critical disease progression stages. Following closely, the diagnostic segment is gaining momentum, reflecting the need for early and accurate disease detection. Innovations in imaging techniques and biomarker identification are enhancing diagnostic capabilities, making non-invasive options more appealing. The lifestyle management sub-segment, focusing on dietary and exercise interventions, is also witnessing growth, as holistic approaches to managing NASH gain traction. Strategic collaborations and partnerships among pharmaceutical companies are accelerating research and development efforts, further propelling market dynamics. As the demand for effective NASH solutions intensifies, stakeholders are increasingly investing in novel therapeutic and diagnostic innovations.

Market Segmentation
TypeBiomarkers, Therapeutics, Diagnostics
ProductPharmaceuticals, Biologics, Nutraceuticals, Medical Devices
ServicesClinical Trials, Consulting Services, Patient Support Services, Regulatory Services
TechnologyGenomics, Proteomics, Bioinformatics, Imaging Technologies
ApplicationLiver Biopsy, Imaging Tests, Blood Tests
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies
StagePreclinical, Phase I, Phase II, Phase III
ModeInvasive, Non-Invasive
SolutionsTherapeutic Solutions, Diagnostic Solutions

Market Snapshot:

The Non-Alcoholic Steatohepatitis (NASH) market is characterized by a dynamic landscape, with significant market share held by key pharmaceutical giants. Pricing strategies remain competitive, influenced by the high demand for innovative therapeutic solutions. Recent product launches have introduced groundbreaking treatments, enhancing the therapeutic arsenal available to healthcare providers. This has led to a competitive pricing environment, as companies vie for market dominance through differentiated product offerings and strategic partnerships. The market is witnessing a surge in research and development investments, driving the introduction of novel drug candidates. In terms of competition benchmarking, the NASH market is intensely competitive, with major players focusing on strategic mergers and acquisitions to bolster their market positions. Regulatory influences are pivotal, with stringent guidelines shaping the approval and commercialization of NASH therapies. The regulatory landscape in North America and Europe is particularly influential, setting high standards for clinical efficacy and safety. This regulatory rigor, coupled with increasing patient awareness, is driving the market's evolution. The competitive landscape is further intensified by emerging biotechnology firms, which are introducing innovative therapeutic approaches, thereby reshaping market dynamics.

Geographical Overview:

The Non-Alcoholic Steatohepatitis (NASH) market is witnessing varied growth across regions, each presenting unique opportunities. North America leads, driven by high obesity rates and rising awareness of liver diseases. The presence of key pharmaceutical companies investing in research and development further propels market growth. Europe follows, with increasing healthcare expenditure and a growing prevalence of lifestyle-related diseases enhancing market prospects. The Asia Pacific region is emerging rapidly, fueled by rising healthcare awareness and improving healthcare infrastructure. Countries like China and India are witnessing significant growth due to an increasing patient pool and government initiatives supporting liver disease research. Latin America shows potential, with Brazil and Mexico at the forefront, driven by lifestyle changes and improved healthcare access. The Middle East & Africa are nascent markets, with countries like Saudi Arabia recognizing the importance of addressing liver diseases, thus offering new growth pockets for NASH therapeutics.

Key Trends and Drivers:

The Non-Alcoholic Steatohepatitis (NASH) market is experiencing notable growth due to increasing prevalence of obesity and type 2 diabetes. These conditions are major risk factors for NASH, driving demand for effective treatments. A significant trend is the development of novel therapeutics targeting specific pathways involved in disease progression. Pharmaceutical companies are investing in research to discover innovative drugs that can halt or reverse liver damage. Rising awareness about liver health and early diagnosis is also propelling market growth. Healthcare providers are emphasizing the importance of screening and early intervention, leading to increased patient engagement. Additionally, advancements in diagnostic technologies are enabling more accurate and non-invasive methods for NASH detection. Regulatory support and expedited approval processes for promising therapies are further accelerating market expansion. The global focus on personalized medicine is creating opportunities for tailored treatment approaches, enhancing patient outcomes. As the understanding of NASH pathophysiology deepens, the market is poised for transformative advancements and lucrative opportunities.

Restraints and Challenges:

The Non-Alcoholic Steatohepatitis (NASH) market is confronted with several significant restraints and challenges. A primary challenge is the complexity of accurately diagnosing NASH, as it often requires invasive liver biopsies, which are both costly and risky for patients. This diagnostic complexity limits early detection and intervention, impeding market growth. Another constraint is the lack of approved therapies specifically targeting NASH, which results in a reliance on off-label treatments. This absence of targeted therapies limits treatment options and market expansion. Furthermore, the high cost of ongoing research and development poses a financial burden, deterring smaller companies from entering the market. The market also faces challenges due to the variability in disease progression among patients, complicating clinical trial designs and outcomes. Lastly, there is a general lack of awareness and understanding of NASH among both healthcare providers and patients, which hampers early diagnosis and treatment efforts, ultimately restraining market growth.

Key Players:

Intercept Pharmaceuticals, Genfit, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Viking Therapeutics, Akero Therapeutics, 89bio, Terns Pharmaceuticals, Inventiva, Cirius Therapeutics, Enyo Pharma, Conatus Pharmaceuticals, Gilead Sciences, Allergan, Novartis

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Non alcoholic Steatohepatitis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Non alcoholic Steatohepatitis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Mode
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Mode
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Non alcoholic Steatohepatitis Market Outlook

  • 4.1 Non alcoholic Steatohepatitis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Non alcoholic Steatohepatitis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Non alcoholic Steatohepatitis Market Size

  • 6.1 Non alcoholic Steatohepatitis Market Size, by Value
  • 6.2 Non alcoholic Steatohepatitis Market Size, by Volume

7: Non alcoholic Steatohepatitis Market, by Type

  • 7.1 Market Overview
  • 7.2 Biomarkers
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Diagnostics
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Non alcoholic Steatohepatitis Market, by Product

  • 8.1 Market Overview
  • 8.2 Pharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Biologics
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Nutraceuticals
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Medical Devices
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Non alcoholic Steatohepatitis Market, by Services

  • 9.1 Market Overview
  • 9.2 Clinical Trials
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consulting Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Patient Support Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Non alcoholic Steatohepatitis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Genomics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Proteomics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Bioinformatics
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Imaging Technologies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Non alcoholic Steatohepatitis Market, by Application

  • 11.1 Market Overview
  • 11.2 Liver Biopsy
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Imaging Tests
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Blood Tests
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Non alcoholic Steatohepatitis Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Non alcoholic Steatohepatitis Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Phase I
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Phase II
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Phase III
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Non alcoholic Steatohepatitis Market, by Mode

  • 14.1 Market Overview
  • 14.2 Invasive
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Non-Invasive
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Non alcoholic Steatohepatitis Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Therapeutic Solutions
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Diagnostic Solutions
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Non alcoholic Steatohepatitis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Stage
    • 16.2.9 North America Market Size and Forecast, by Mode
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Stage
      • 16.2.9.8 United States Market Size and Forecast, by Mode
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Stage
      • 16.2.10.8 Canada Market Size and Forecast, by Mode
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Stage
    • 16.3.9 Europe Market Size and Forecast, by Mode
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Stage
      • 16.3.10.8 Germany Market Size and Forecast, by Mode
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Stage
      • 16.3.11.8 France Market Size and Forecast, by Mode
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Stage
      • 16.3.12.8 Spain Market Size and Forecast, by Mode
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Stage
      • 16.3.13.8 Italy Market Size and Forecast, by Mode
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Stage
      • 16.3.15.8 Sweden Market Size and Forecast, by Mode
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Stage
      • 16.3.17.8 Denmark Market Size and Forecast, by Mode
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Stage
      • 16.3.18.8 Finland Market Size and Forecast, by Mode
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Stage
      • 16.3.19.8 Russia Market Size and Forecast, by Mode
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Stage
      • 16.4.9.8 China Market Size and Forecast, by Mode
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Stage
      • 16.4.10.8 India Market Size and Forecast, by Mode
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Stage
      • 16.4.11.8 Japan Market Size and Forecast, by Mode
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Stage
      • 16.4.12.8 South Korea Market Size and Forecast, by Mode
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Stage
      • 16.4.13.8 Australia Market Size and Forecast, by Mode
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Stage
      • 16.4.14.8 Singapore Market Size and Forecast, by Mode
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Stage
    • 16.5.9 Latin America Market Size and Forecast, by Mode
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Stage
      • 16.5.9.8 Brazil Market Size and Forecast, by Mode
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Stage
      • 16.5.10.8 Mexico Market Size and Forecast, by Mode
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Stage
      • 16.5.11.8 Argentina Market Size and Forecast, by Mode
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Stage
      • 16.6.10.8 UAE Market Size and Forecast, by Mode
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Stage
      • 16.6.11.8 South Africa Market Size and Forecast, by Mode
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Intercept Pharmaceuticals
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Genfit
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Madrigal Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Galmed Pharmaceuticals
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Viking Therapeutics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Akero Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 89bio
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Terns Pharmaceuticals
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Inventiva
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Cirius Therapeutics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Enyo Pharma
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Conatus Pharmaceuticals
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Gilead Sciences
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Allergan
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Novartis
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제